Author/Authors :
Nikoufar, Maryam Division of Pediatric Cardiology - Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Zeinaloo, Ali-Asghar Division of Pediatric Cardiology - Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Mahdavi, Chehreh Division of Pediatric Cardiology - Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Aghaei Moghadam, Ehsan Division of Pediatric Cardiology - Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Kocharian, Armen Division of Pediatric Cardiology - Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Kompani, Farzad Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Ghamari, Azin Tehran University of Medical Sciences - Tehran, Iran , Mirzaaghayan, Mohammad Reza Division of Pediatric Cardiology - Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Majnoon, Mohammad Taghi Division of Pediatric Cardiology - Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Koochakzade, Leili Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran , Safari, Aalie Children’s Medical Center Tehran University of Medical Sciences - Tehran, Iran
Abstract :
Despite high effectiveness of Anthracycline as a potent antineoplastic agent, its-related cardiothoxicity is the most notorious
complication. The purpose of our study was to assess the value of using different methods (LVEF, E, E’, A and Tei index versus
global longitudinal strain) for detection of early cardiac changes by measuring them before and one month after the Anthracycline
administration in a cross-sectional cohort study.
Methods: This cross-sectional study was performed on 22 new diagnosed cancer patients aged 18 years or younger who referred
to the children Medical center in Tehran in 2016 as the cases and also 22 age-matched healthy children who referred to the center
because of any non-cardiac reasons as the control. All participants were assessed to determine the left ventricular functional indices
before and also one month after starting the therapeutic regimen containing Anthracycline.
Results: Among all parameters assessed by echocardiography, only the mitral annular peak systolic velocity (Sm) significantly reduced
after administrating Anthracycline compared to before that. Data for patients and the control group showed no statistical
significant differences before the therapy as well.
Conclusions: Our findings show that evaluating Sm is most useful for early detection of cardiac changes. This may be due to our
limitation of small cohort studies and also the short interval after the drug administration; although this was related to the main
goal of our study.
Keywords :
Strain Anthracycline , Ventricular Function , Echocardiography , Chemotherapy